123 related articles for article (PubMed ID: 232237)
1. Application of indirect hemagglutination test to measurement of type specific antibody to herpes simplex virus in human sera.
Ohashi M; Ozaki Y
Microbiol Immunol; 1979; 23(8):801-4. PubMed ID: 232237
[No Abstract] [Full Text] [Related]
2. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
[No Abstract] [Full Text] [Related]
3. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibodies against herpes simplex and adenovirus in oral and cervical cancer patients--a preliminary report.
Kumari TV; Shanmugam J; Prabha B; Vasudevan DM
Indian J Med Res; 1982 Apr; 75():590-2. PubMed ID: 6286474
[No Abstract] [Full Text] [Related]
5. [Serological aspects of the relation between herpes virus and cervico-uterine cancer].
Suárez M; Del Campo G; Ojeda JM
Rev Chil Obstet Ginecol; 1983; 48(1):11-5. PubMed ID: 6099904
[No Abstract] [Full Text] [Related]
6. Association of herpes simplex type 2 virus with cervical cancer of the uterus.
Kao CL; Chen YH; Tang MC; Wen HK; Hsia S
Taiwan Yi Xue Hui Za Zhi; 1974 Feb; 73(2):122-7. PubMed ID: 4368434
[No Abstract] [Full Text] [Related]
7. Variations of cytotoxic antibodies to cells with herpes simplex virus antigens in women with progressing or regressing cancerous lesions of the cervix.
Thiry L; Sprecher-Goldberger S; Fassin Y; Gould I; Gompel C; Pestiau J; De Halleux F
Am J Epidemiol; 1974 Oct; 100(4):251-61. PubMed ID: 4370721
[No Abstract] [Full Text] [Related]
8. Measurement of antibodies to herpesvirus types 1 and 2 in human sera by microradioimmunoassay.
Jankowski MA; Petersen EE; Böcker JF
Acta Virol; 1977 Sep; 21(5):405-11. PubMed ID: 22235
[TBL] [Abstract][Full Text] [Related]
9. [Sensitivity and specificity of the passive hemagglutination reaction applied to titration of herpes antibodies].
Huraux JM; Bogossian M; Fortier B; Bricout F
Pathol Biol (Paris); 1976 May; 24(5):325-8. PubMed ID: 181718
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to Herpes simplex virus types 1 and 2 in patients with squamous-cell carcinoma of uterine cervix in India.
Seth P; Prakash SS; Ghosh D
Int J Cancer; 1978 Dec; 22(6):708-14. PubMed ID: 214407
[TBL] [Abstract][Full Text] [Related]
11. Antibody to herpes simplex virus type 2-induced nonstructural proteins in women with cervical cancer and in control groups.
Anzai T; Dreesman GR; Courtney RJ; Adam E; Rawls WE; Benyesh-Melnick M
J Natl Cancer Inst; 1975 May; 54(5):1051-9. PubMed ID: 165303
[TBL] [Abstract][Full Text] [Related]
12. Comparison of indirect hemagglutination and indirect immunofluorescence tests with microneutralization tests for detection of type-specific Herpesvirus hominis antibody.
Johnson LD; Fuccillo DA; Stalder H; Oxman MA; Fraser CE; Madden DL
J Clin Microbiol; 1979 Mar; 9(3):384-90. PubMed ID: 222800
[TBL] [Abstract][Full Text] [Related]
13. IgM antibody to a tumor-associated antigen (AG-4) induced by herpes simplex virus type 2: its use in location of the antigen in infected cells.
Aurelian L; Smith MF; Cornish DJ
J Natl Cancer Inst; 1976 Mar; 56(3):471-7. PubMed ID: 176392
[TBL] [Abstract][Full Text] [Related]
14. Immunity, herpes simplex virus, and cervical carcinoma.
Mumford DM; Kaufman RH; McCormick N
Surg Clin North Am; 1978 Feb; 58(1):39-54. PubMed ID: 205961
[No Abstract] [Full Text] [Related]
15. Increasing antibody titers to herpes simplex virus type 2 during follow-up of women with cervical dysplasia.
Sprecher-Goldberger S; Thiry L; Gould I; Fassin Y; Gompel C
Am J Epidemiol; 1973 Feb; 97(2):103-10. PubMed ID: 4347508
[No Abstract] [Full Text] [Related]
16. The use of monoclonal antibodies in (reverse) passive haemagglutination tests for herpes simplex virus antigens and antibodies.
Cranage MP; McLean CS; Buckmaster EA; Minson AC; Wildy P; Coombs RR
J Med Virol; 1983; 11(4):295-306. PubMed ID: 6308140
[TBL] [Abstract][Full Text] [Related]
17. A review of the identification and titration of antibodies to herpes simplex viruses type 1 and type 2 in human sera.
Plummer G
Cancer Res; 1973 Jun; 33(6):1469-76. PubMed ID: 4352384
[No Abstract] [Full Text] [Related]
18. Herpes simplex virus and human cancer. III. Search for relationship of herpes simplex antibodies and cervical dysplasia and labial neoplasia.
Rotola A; Gerna G; Di Luca D; Virgili AR; Manservigi R; Cassai E
Tumori; 1983 Apr; 69(2):83-7. PubMed ID: 6304957
[TBL] [Abstract][Full Text] [Related]
19. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
Ito H; Kurihara S; Nishimura C
Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
[No Abstract] [Full Text] [Related]
20. Neutralising antibody against type 1 and type 2 herpes simplex virus in cervical mucus of women with cervical intra-epithelial neoplasia.
Murphy JF; Murphy DF; Barker S; Mylotte ML; Coughlan BM; Skinner GR
Med Microbiol Immunol; 1985; 174(2):73-80. PubMed ID: 2993833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
